2015
DOI: 10.1021/acs.bioconjchem.5b00266
|View full text |Cite
|
Sign up to set email alerts
|

Growth Factor Tethering to Protein Nanoparticles via Coiled-Coil Formation for Targeted Drug Delivery

Abstract: Protein-based nanoparticles are attractive carriers for drug delivery because they are biodegradable and can be genetically designed. Moreover, modification of protein-based nanoparticles with cell-specific ligands allows for active targeting abilities. Previously, we developed protein nanoparticles comprising genetically engineered elastin-like polypeptides (ELPs) with fused polyaspartic acid tails (ELP-D). Epidermal growth factor (EGF) was displayed on the surface of the ELP-D nanoparticles via genetic desig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
40
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(40 citation statements)
references
References 27 publications
0
40
0
Order By: Relevance
“…Due to its relatively straightforward design and the ubiquitous expression of EGFR on many cell types, the EGF tethering system has a wide array of potential applications in regenerative medicine. Growth factor tethering (and specifically EGF tethering) has been used in a variety of contexts, including improving survival of other cell types such as vascular smooth muscle cells [31] or targeted therapeutic growth factor delivery [32, 33]. In the context of MSC clinical utility, although this study analyzed the effects of tEGF on a construct designed primarily for bone regeneration, the applications of EGF tethering may also extend outside of tricalcium phosphate scaffolds and bone repair in general.…”
Section: Resultsmentioning
confidence: 99%
“…Due to its relatively straightforward design and the ubiquitous expression of EGFR on many cell types, the EGF tethering system has a wide array of potential applications in regenerative medicine. Growth factor tethering (and specifically EGF tethering) has been used in a variety of contexts, including improving survival of other cell types such as vascular smooth muscle cells [31] or targeted therapeutic growth factor delivery [32, 33]. In the context of MSC clinical utility, although this study analyzed the effects of tEGF on a construct designed primarily for bone regeneration, the applications of EGF tethering may also extend outside of tricalcium phosphate scaffolds and bone repair in general.…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, the combination of coiled-coil heterodimers that are able to form nanoparticles with targeted drug delivery enhances tumor suppression and increases apoptotic cell death. This study demonstrates that customized drug-delivery systems that target different cell types and receptors can be constructed using ELRs and may be a good candidate for cancer therapy applications [58].…”
Section: Advanced Strategies For Elr Nanoparticle Formationmentioning
confidence: 87%
“…These systems also offer the potential for multi-valent drug binding, which improves the loading efficiency by minimizing the entropic penalty for binding. Assuming one chain in a heterodimeric coiled-coil system contains a single binding site, its sequence may be doubled to introduce a second binding site (Assal et al 2015). Recently, Klok and co-workers investigated a heterodimeric coiled-coil carrier comprising two peptides (K 3 and E 3 ), which self-assemble at pH 7.0, but dissociate at pH 5.0 (endosomal pH), thereby releasing their cargo (Apostolovic et al 2010(Apostolovic et al , 2011.…”
Section: Coiled-coil Therapeuticsmentioning
confidence: 99%